Don Sin retweeted
Very severe long COVID was linked to distinct mouth and lung bacteria six months after hospital discharge, but whether those differences predated infection remains unknown. @EuroRespSoc medicalxpress.com/news/2026-…
Don Sin retweeted
In the latest ERJ Podcast, Deputy Chief Editor Don Sin interviews Marlies van Dijk (University of Groningen, Groningen, Netherlands) about her multicentre randomised crossover trial of fentanyl & morphine for persistent dyspnoea in COPD: channel.ersnet.org/channel-8…
@ERSpublications
Don Sin retweeted
Use of e-cigarettes makes it more likely that young people will experience mental-health disorders and take up smoking. Governments must act
go.nature.com/4dZ5y9G
Don Sin retweeted
NETs in pleural infection: biological signal or clinical tool? publications.ersnet.org/cont…
Don Sin retweeted
This months ERJ is an absolute blockbuster - check it out!
Clinical practice guideline for long COVID prevention and treatment - publications.ersnet.org/cont…
Pulmonary hypertension associated with interstitial lung disease: a state-of-the-art review- publications.ersnet.org/cont…
Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults: an ERS statement- publications.ersnet.org/cont…
Clarifying the GOLD 2026 guidance for initial pharmacological COPD treatment-publications.ersnet.org/cont…
Nerandomilast in progressive pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-ILD trial- publications.ersnet.org/cont…
publications.ersnet.org/cont…
Don Sin retweeted
The European Respiratory Journal impact factor, released today, has increased to 23.8, its highest ever level outside of the COVID-19 pandemic.
We are incredibly proud of the high scientific impact of the ERJ @ERSpublications and very grateful to authors, reviewers, our outstanding publication office team and our outstanding editors.
Respiratory Journal IFs
Lancet Resp 34.7
ERJ 23.8
Journal of thoracic Oncology 23.3
AJRCCM 21.7
ERR 10.8
CHEST 9.8
Thorax 9.1
@EuroRespSoc @donsin4
Don Sin retweeted
🚨New Journal Impact Factors 🚨
ERJ is now ranked 2nd in the Respiratory System category, with a JIF of 23.8.
The European Respiratory Review’s JIF has seen an increase to 10.8, ERJ Open Research’s to 4.4 and Breathe’s to 4.5.
Don Sin retweeted
ICYMI: Canada’s top-skilled workers are leaving for the U.S. in droves for lower taxes and higher pay: TD study
thehub.ca/2026/05/28/canadas…
Don Sin retweeted
Among adults in a pooled cohort drawn from eight US population studies, #COPD was associated with reduced life expectancy, with years of life lost increasing across Global Initiative for Chronic Obstructive Lung Disease stages.
#ATS2026 @atscommunity
ja.ma/4deeYyl
Don Sin retweeted
🎙️ERJ Podcast: listen as @ProfJDChalmers interviews Associate Editor Sanja Stanojevic about the joint statement from GOLD and the GLI regarding the use of spirometry to define airflow obstruction and diagnose COPD, published in the April issue of the ERJ:
channel.ersnet.org/channel-8…
Don Sin retweeted
You've seen it a hundred times: a graph, a P-value under 0.05, and a claim that a treatment "works."
But statistical significance is not the same as clinical significance.
In this video JCP Section Editor Dr. Leslie Citrome breaks down why P-values alone can mislead your treatment decisions — and what to use instead. The key shift: move from relative effect sizes (which can make modest findings look dramatic) to absolute measures like Number Needed to Treat (NNT).
A drug that cuts risk by 20% sounds impressive. But if baseline risk is 0.49%, you're looking at an absolute reduction of 0.08%. That context changes everything at the point of care.
NNT gives you a practical, patient-level lens: how many people need to receive this treatment before one additional person benefits? Smaller NNT = bigger real-world difference.
Next time a rep or a journal headline leads with a P-value, ask for the NNT. It's the number that actually helps you decide.
🎥 Watch Dr. Citrome's full commentary here -----> bit.ly/48JwK9N
Don Sin retweeted
Tens of thousands of publications from 2025 might include invalid references generated by AI, a Nature analysis suggests
go.nature.com/4dnjvil
Don Sin retweeted
Last week to submit – deadline 31 March!
The European Respiratory Journal seeks high-quality papers on respiratory infections for a special series due to be published later this year. Submit before the deadline: mc.manuscriptcentral.com/erj
Don Sin retweeted
In a post-hoc analysis of the COSMOS randomized trial, supplementation with daily multivitamins, but not with cocoa extract, over the course of 2 years decreased biological aging, as measured by epigenetic aging clocks nature.com/articles/s41591-0…
Don Sin retweeted
The 13 hallmarks of the aging lung... @ERSpublications doi.org/10.1183/13993003.012…
Don Sin retweeted
Divergent recommendations about spirometry interpretation have confused primary and secondary care clinicians, as well as lung specialists. GOLD and GLI have now agreed how spirometry should be interpreted, issuing a joint statement @EuroRespSoc regarding the use of spirometry to define airflow obstruction and diagnose COPD.
publications.ersnet.org/cont…
Don Sin retweeted
🎙️ In the latest ERJ Podcast, Deputy Chief Editor Don Sin interviews David Halpin about his Viewpoint editorial on the global challenges of COPD and asthma, published in the most recent issue of the ERJ.
Listen to the episode: channel.ersnet.org/channel-8…
Don Sin retweeted
Submit your best work to the high impact ERJ!
Call for papers!
The European Respiratory Journal seeks high-quality papers on respiratory infections for a series due to be published later in 2026, with particular focus on acute & chronic conditions across various specialties.
Learn more & submit: ersnet.org/news-and-features…
Don Sin retweeted
Get your abstracts in for the best respiratory meeting in the world ❤️
The submission of abstracts (first round) and clinical cases ends tomorrow (12 February) for the #ERSCongress 2026 (5–9 September, 2026 in Barcelona, Spain and online)!
Don't miss this opportunity – submit online: ersnet.org/congress-and-even…
